NCT07064863 2025-07-17
BCG-TIME
Queen's University
Phase 1/2 Not yet recruiting
Clinical Trials
5 trialsNCT02792192 2021-10-28
Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants
Hoffmann-La Roche
Phase 1/2 Terminated
NCT02010203 2020-02-17
A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT
Heat Biologics
Phase 1/2 Terminated
NCT00007826 2013-09-20
Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00016133 2013-05-30
Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery
National Cancer Institute (NCI)
Phase 1/2 Completed